Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the feasibility, safety, and preliminary effects of ketamine-assisted group therapy specifically designed for Spanish-speaking adults with depression. This pilot clinical trial aims to explore how this culturally adapted group-based ketamine intervention works in a community setting for participants who meet criteria for major depressive disorder. Participants will receive ketamine-assisted psychotherapy delivered in a group format. This is an open-label, single-arm study where all participants undergo the same therapy. The intervention focuses on combining ketamine treatment with group psychotherapy tailored to Spanish-speaking adults. The study does not include a comparison group or placebo. During the study, participants will be monitored for safety and changes in psychiatric symptoms, wellbeing, and health behaviors. Assessments will occur at one week and twelve weeks after the intervention to evaluate feasibility, safety, and early signs of effect. Participants are expected to have an ongoing relationship with a psychiatrist and primary care provider during the trial, which will last until July 2027.
Actively Recruiting
This research aims to evaluate if adding an artificial intelligence AI algorithm to analyze fundus photographs, along with measuring eye pressure and visual field testing, can improve glaucoma screening. The study focuses on people with diabetes since they have a higher risk of developing glaucoma. Integrating glaucoma screening into existing diabetic eye disease DED programs may help detect glaucoma earlier and prevent vision loss. Participants are divided into two groups. One group will have their fundus photos analyzed by AI for glaucoma signs, along with eye pressure measurement, and if needed, virtual reality visual field testing. The other group will receive routine diabetic eye disease screening, including AI analysis for diabetic retinopathy only. This study uses devices like the Icare tonometer and Olleyes virtual reality system to assess eye health. During the study, participants will have fundus images taken as part of diabetic eye screening and eye pressure measured. If glaucoma is suspected, additional side vision testing will be conducted using a headset. Researchers will monitor glaucoma detection one year after screening and assess cost-effectiveness, participant satisfaction, and knowledge about glaucoma on the day of screening. The study is expected to run until September 2030.